From warning letter to wellness label: how WHOOP reset the rules
When people talk about wearable blood pressure FDA wellness policy, they are really talking about what happened to WHOOP. In November 2023, the Food and Drug Administration sent WHOOP a warning letter about its Blood Pressure Insights feature, then closed the case in mid‑2024 after the company stripped out diagnostic language and reframed the feature as a low‑risk general wellness tool. The FDA’s letter, posted on its website on November 29, 2023, and the subsequent close‑out notice in June 2024, spelled out how the company had to move away from medical device positioning and toward a wellness‑oriented description of its blood pressure–style insights.
WHOOP’s feature still uses optical sensors to measure blood‑related signals and infer pressure trends, but the app now avoids any promise to measure blood pressure with clinically validated accuracy. Instead of claiming precise systolic and diastolic values or suggesting that the device can guide treatment, the product now talks about day–night patterns, blood pressure variability over time, and general wellness guidance that might prompt lifestyle changes. In practice, that means the wearable device can show pressure monitoring graphs and pressure‑style alerts about unusual shifts, yet it must stop short of saying you have hypertension or need medical care.
The FDA’s updated General Wellness guidance for low‑risk devices and its broader digital health policy documents draw a bright line between wellness products and medical devices. If a wearable monitor or app focuses on supporting wellness, avoids diagnostic or treatment claims, and presents its data as informational, the agency treats it as a low enforcement priority under its general wellness policy. For buyers, that means many pressure devices on the market, from WHOOP straps to multi‑sport smartwatches, can offer blood pressure–style insights without going through the same clinical trials and Food and Drug Administration regulatory pathways required for a full medical device cuff.
For someone choosing between advanced health devices, this nuance matters more than the marketing gloss. A wearable blood pressure FDA wellness feature can be useful for spotting general patterns, but it is not a substitute for a clinically validated upper arm cuff that your clinician trusts. Peer‑reviewed comparisons often find that optical wearables can miss rapid changes or drift by several millimeters of mercury compared with a calibrated cuff, especially during movement. For example, a 2020 study in Hypertension Research and a 2021 paper in the Journal of Clinical Hypertension both reported average differences in the 5–10 mmHg range between wrist‑based optical estimates and reference cuffs under real‑world conditions. If you want to see how different products handle swim tracking, GPS accuracy, and heart rate stability alongside these new wellness features, a comparative test such as this open water multi watch review gives a clearer sense of how the overall device performs on your wrist.
Wellness versus medical device: what your wrist data can and cannot say
The practical difference between a wellness product and a regulated medical device comes down to claims, testing, and accountability. Under the FDA’s General Wellness: Policy for Low Risk Devices guidance, a wearable that tracks heart rate, blood oxygen, and estimated blood pressure can stay out of the medical devices category if it avoids saying it diagnoses, treats, or cures disease. That is why you now see language about supporting health, encouraging care seeking, and offering wellness‑oriented insights, instead of firm statements that a device can measure blood pressure with medical precision.
For consumers, this means your wearable blood pressure FDA wellness feature sits in the same bucket as stress scores, HRV‑based readiness, and sleep staging. The data can highlight trends, such as higher blood pressure estimates on stressful workdays or different readings between day–night periods, but it is not clinically validated the way a hospital‑grade monitor is. Published studies comparing wrist‑based wearables with upper arm cuffs often report average differences of 5–10 mmHg and wider spreads in individual cases, which is why the FDA still treats most of these products as general wellness tools rather than cleared medical devices. As one primary care physician put it to a patient who brought in weeks of wrist‑based readings, “Your watch is a great early warning system, but I still adjust your medication based on the cuff on the wall, not the graph on your phone.”
That gap shows up when you bring your wearable to a clinic and compare readings. A nurse using a calibrated cuff and a dedicated pressure monitor will rely on those clinical data points to adjust medication, while your wearable’s pressure monitoring graph is treated as background context. You can still share the app screenshots with your doctor, yet they will usually treat this wellness guidance as directional information that might prompt proper testing rather than as evidence to change care on its own.
Shoppers weighing different devices should read the fine print around blood pressure and related metrics. A general wellness wearable may talk about low‑risk insights, limited regulatory oversight, and support for health care conversations, but it will not promise diagnostic accuracy or use the term medical device in its marketing. If you want a more traditional tracker that focuses on steps, heart rate, and sleep while staying clear about its limits, a mainstream option such as the kind of smartwatch with heart rate and sleep monitoring may be enough for your needs.
How to use wearable blood pressure insights without overtrusting them
For Apple Watch, Samsung Galaxy Watch, Garmin, Oura, and other brands, the WHOOP case signals how far they can push health features before triggering stricter FDA oversight. They can build devices and apps that monitor heart rate, estimate blood oxygen, and even infer blood pressure, as long as they frame these as wellness products that support general wellness rather than as tools that replace clinical care. That is why you often see disclaimers saying not medical grade, not for diagnosis, and not a substitute for a medical device cuff.
In daily life, the smartest way to use a wearable blood pressure FDA wellness feature is as an early nudge, not a final verdict. If your device shows consistently high pressure estimates, especially across day–night cycles, treat that as a reason to schedule a proper check with a clinically validated upper arm cuff at a pharmacy or clinic. When the wearable’s blood pressure trends line up with those independent readings within a few points, you can feel more confident using the app’s pressure monitoring graphs to track how changes in food, drug regimens, exercise, or stress management affect your cardiovascular health and overall wellness.
People who are deeply into health data often pair a wellness product on the wrist with a separate medical device at home. They might use a connected pressure monitor that is cleared as a medical device for home health care, then compare those readings with the wearable’s pressure estimates to understand the gap. If the difference stays within a few millimeters of mercury under resting conditions, the wearable becomes a convenient general wellness tool for spotting patterns between clinic visits.
For a more advanced view of how continuous monitoring, dual PPG and ECG sensors, and long battery life can support this kind of hybrid approach, look at a detailed test of a fitness tracker with 24/7 health tracking and wellness insights. Used wisely, these products can bridge the gap between everyday wellness and formal clinical care, as long as you remember that the most important number is not the step count but what you do with it.
FAQs: optical blood pressure accuracy and wearable blood pressure vs cuff
How accurate is optical blood pressure on a smartwatch or fitness band?
Optical blood pressure estimates rely on light‑based sensors and algorithms, so they tend to be less precise than a calibrated upper arm cuff. Studies published between 2019 and 2022 commonly report average differences of around 5–10 mmHg, with larger errors during movement, intense exercise, or poor fit.
Can a wearable blood pressure feature replace a traditional cuff?
No. A wearable blood pressure FDA wellness feature is designed for general wellness and trend tracking, not for diagnosis or medication changes. Clinicians still depend on validated cuffs that meet formal accuracy standards when they decide whether you have hypertension or need treatment adjustments.
Why does the FDA treat most wrist‑based blood pressure tools as wellness products?
The FDA’s General Wellness policy allows low‑risk products that support a healthy lifestyle or help users understand general health trends to avoid full medical device regulation, as long as they do not claim to diagnose, treat, or cure disease. Because most optical systems have not met strict validation criteria, they are usually marketed as wellness tools instead of regulated blood pressure monitors.